Immunservice

Immunservice GmbH uses highly effective and extremely well tolerated immune hormones to develop drugs according to biomimetic

Immunservice is focused on research about immune hormone interleukin-2 and offers resources and insights to implement diagnostic and pharmaceutical developments of it. It develops solutions that focus on human and animal immunotherapy, and human cell therapy. Immunservice develops medicinal forms of interlelukin-2 that enable patients with lung metastases to prevent suffocation. Immunservice was founded by Edith Huland in 2007.